The RAPID-Health & AI Fall 2023 Go Digital edition is a 4-weeks online program, which includes two major components.
The first component is a series of interactive live Webinars with seasoned health sector experts, on diverse knowledge areas related to the European Health & Life Sciences market. The business topics covered include insights on European healthcare systems, Funding, VCs, business models and more.
The second component consists of Individual Consulting hours. Each participating startup will receive 6 hours of 1-on-1 consultancy services provided by ROM Utrecht Region and Tiger Accelerator, with a focus on helping the startups to identify their best course of action for entering the Dutch & European Health markets.
International health sector startups interested in entering the Dutch & European markets are welcome to apply.
After RAPID, you will have insights on:
What the next steps should be...
to successfully contact your potential launching customer(s).
for the Market access plan approach.
How your product / service...
fits the healthcare market in Utrecht/Netherlands/Europe.
could be reimbursed by Health insurer in the Netherlands.
fits as part of a supply chain with Dutch/Utrecht partners.
could fit the business of health organisations.
What needs to be done in order to...
validate for medical use in the Netherlands and Europe.
convince your potential launching customer (customer demand and orientation)
access the possibilities for getting funding (VC/Grants/BA/...)
The RAPID-Health & AI Fall 2023 Go Digital 4-weeks program will last from Nov 1 to Nov 31.
July 8, 2023 | Open Call for participation RAPID-Health & AI Fall 2023
September 30, 2023 | Deadline for application
October 13, 2023 | Pre-qualification results: Pitch events candidates invited
October 20, 2023 | Pitching your startup in front of an international jury for RAPID program selection
October 23, 2023 | Decision by the international jury for definitive RAPID Program participation.
November 1, 2023 | Starting RAPID-Health & AI Fall 2023 Go Digital
The RAPID-Health & AI Fall 2023 Go Digital program's registration fees for intake is EUR 100.
The RAPID-Health & AI Fall 2023 Go Digital program is provided for a program fee of EUR 5,000, for companies that are selected to participate by the international jury.
Note: After the 4-weeks program, qualified companies can enter the RAPID Intensive Coaching phase with a starting duration of 3 months, for a monthly fee of € 3,500, including investment opportunities.
After Fall 2023: RAPID Intensive Coaching
At the end of the The RAPID-Health & AI Fall 2023 Go Digital program, participating companies will be evaluated based on factors such as Technology Readiness Level, product-market fit, and other key criteria, to determine whether they qualify for the next phase of RAPID: the Intensive Coaching phase.
Companies whose profiles meet the specifications of the program can choose to enter the Intensive Coaching phase for a fee of € 3,000. This advanced phase of RAPID presents customised and substantial softlanding opportunities for every company to enter the European Health & Life Sciences market.
With a starting duration of 3 months, the RAPID Intensive Coaching phase includes:
Access to Market trajectory: Customised business development consulting and matchmaking services provided by Tiger Accelerator in cooperation with Taiwan Business Association and ROM Utrecht Region Team Impact.
Access to Funding trajectory: Networking services and matchmaking services with Angel Investors, Venture Capital, Corporate Venture Capital and other sources of funding.
Regular online support and consulting hours provided by ROM Utrecht Region & Tiger Accelerator.
Supported by organising partners in startup’s own region/country.
How to apply:
Applications can be made via the application form.
For any inquiry about the RAPID-Health & AI Programs, please contact:
Our team of experts consultants from the Netherlands & Taiwan is composed of senior business professionals and governance leaders experienced with various aspects of accessing the European Health & Life Sciences market. Some members of the team include: